Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Sophia Genetics SA (SOPH) stands at the forefront of data-driven medicine, delivering advanced genomic and clinical data analytics that significantly enhance patient outcomes. Utilizing cutting-edge machine learning technologies, the company provides an integrated platform designed to help healthcare providers navigate complex genomic data, facilitating personalized treatment strategies in oncology, rare diseases, and hereditary conditions. With a robust global footprint and strategic partnerships with leading healthcare organizations, Sophia Genetics is well-positioned to transform the precision medicine landscape and solidify its role as a key player in the genomics industry.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$7.87
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 4, 2026 | $-0.15 | $-0.26 | Miss -73.3% | — | $21.72M | $23.31M | +7.3% | 1D Pre+0.4% | On-Day+20.2% | 1D Post-7.9% |
Q ended Mar 31, 2026 Reported May 5, 2026 | $-0.24 | $-0.19 | Beat +20.8% | — | $20.4M | $21.69M | +6.3% | 1D Pre-0.6% | On-Day-4.2% | 1D Post-1.0% |
Q ended Dec 31, 2025 Reported Mar 3, 2026 | $-0.22 | $-0.17 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| Beat +22.7% |
| — |
| $20.89M |
| $21.71M |
| +3.9% |
| 1D Pre+2.7% |
| On-Day-11.3% |
| 1D Post+3.0% |
Q ended Sep 30, 2025 Reported Nov 4, 2025 | $-0.20 | $-0.20 | Met 0.0% | — | $18.13M | $19.46M | +7.3% | 1D Pre0.0% | On-Day-6.4% | 1D Post-3.4% |